Detalles de la búsqueda
1.
Dynamic borrowing of historical controls adjusting for covariates in vaccine efficacy clinical trials.
Pharm Stat
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38591424
2.
Vaccine clinical trials with dynamic borrowing of historical controls: Two retrospective studies.
Pharm Stat
; 22(3): 475-491, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606496
3.
Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study.
J Infect Dis
; 223(9): 1576-1581, 2021 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32887990
4.
Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up study.
Asia Pac J Clin Oncol
; 19(4): 458-467, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36101936
5.
Inference under covariate-adaptive randomization: A simulation study.
Stat Methods Med Res
; 30(4): 1072-1080, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504277
6.
Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial.
Hum Vaccin Immunother
; 17(4): 955-964, 2021 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33180670
7.
Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children.
Infect Dis Ther
; 9(4): 785-796, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710245
8.
Long-term persistence of immune response to the AS04-adjuvanted HPV-16/18 vaccine in Chinese girls aged 9-17 years: Results from an 8-9-year follow-up phase III open-label study.
Asia Pac J Clin Oncol
; 16(6): 392-399, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32780946
9.
Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials.
J Natl Cancer Inst
; 112(8): 818-828, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31697384
10.
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study.
EClinicalMedicine
; 23: 100353, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32639485
11.
Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types.
Expert Rev Vaccines
; 18(3): 309-322, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739514
12.
A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years.
Hum Vaccin Immunother
; 15(7-8): 1970-1979, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31268383
13.
Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial.
Pediatr Infect Dis J
; 38(10): 1061-1067, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31469776
14.
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study.
Hum Vaccin Immunother
; 15(2): 317-326, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30431387
15.
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial.
Cancer Med
; 8(14): 6195-6211, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31305011
16.
Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
BioDrugs
; 32(2): 139-152, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29589230
17.
Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis.
Hum Vaccin Immunother
; 13(1): 237-244, 2017 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27657348
18.
Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.
Hum Vaccin Immunother
; 13(1): 120-127, 2017 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27629913
19.
Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants.
Hum Vaccin Immunother
; 13(3): 588-598, 2017 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27768515
20.
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial.
Cancer Med
; 6(1): 12-25, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27998015